Suppr超能文献

嵌入纤维蛋白支架的人胚胎干细胞来源的心脏祖细胞的长期功能益处。

Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold.

作者信息

Bellamy Valérie, Vanneaux Valérie, Bel Alain, Nemetalla Hany, Emmanuelle Boitard Solène, Farouz Yohan, Joanne Pierre, Perier Marie-Cécile, Robidel Estelle, Mandet Chantal, Hagège Albert, Bruneval Patrick, Larghero Jérôme, Agbulut Onnik, Menasché Philippe

机构信息

INSERM U970, Hôpital Européen Georges Pompidou, Paris, France.

Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Cell Therapy Unit and Clinical Investigation Center in Biotherapies (CBT501), INSERM UMR1160, Université Sorbonne Paris Cité, Paris, France.

出版信息

J Heart Lung Transplant. 2015 Sep;34(9):1198-207. doi: 10.1016/j.healun.2014.10.008. Epub 2014 Nov 7.

Abstract

BACKGROUND

Cardiac-committed cells and biomimetic scaffolds independently improve the therapeutic efficacy of stem cells. In this study we tested the long-term effects of their combination.

METHODS

Eighty immune-deficient rats underwent permanent coronary artery ligation. Five to 7 weeks later, those with an echocardiographically measured ejection fraction (EF) ≤55% were re-operated on and randomly allocated to receive a cell-free fibrin patch (n = 25), a fibrin patch loaded with 700,000 human embryonic stem cells (ESC) pre-treated to promote early cardiac differentiation (SSEA-1(+) progenitors [n = 30]), or to serve as sham-operated animals (n = 25). Left ventricular function was assessed by echocardiography at baseline and every month thereafter until 4 months. Hearts were then processed for assessment of fibrosis and angiogenesis and a 5-component heart failure score was constructed by integrating the absolute change in left ventricular end-systolic volume (LVESV) between 4 months and baseline, and the quantitative polymerase chain reaction (qPCR)-based expression of natriuretic peptides A and B, myosin heavy chain 7 and periostin. All data were recorded and analyzed in a blinded manner.

RESULTS

The cell-treated group consistently yielded better functional outcomes than the sham-operated group (p = 0.002 for EF; p = 0.01 for LVESV). Angiogenesis in the border zone was also significantly greater in the cell-fibrin group (p = 0.006), which yielded the lowest heart failure score (p = 0.04 vs sham). Engrafted progenitors were only detected shortly after transplantation; no grafted cells were identified after 4 months. There was no teratoma identified.

CONCLUSIONS

A fibrin scaffold loaded with ESC-derived cardiac progenitors resulted in sustained improvement in contractility and attenuation of remodeling without sustained donor cell engraftment. A paracrine effect, possibly on innate reparative responses, is a possible mechanism for this enduring effect.

摘要

背景

心脏定向细胞和仿生支架可独立提高干细胞的治疗效果。在本研究中,我们测试了它们联合使用的长期效果。

方法

80只免疫缺陷大鼠接受永久性冠状动脉结扎。5至7周后,对那些经超声心动图测量射血分数(EF)≤55%的大鼠再次进行手术,并随机分配接受无细胞纤维蛋白贴片(n = 25)、负载700,000个人类胚胎干细胞(ESC)且经过预处理以促进早期心脏分化的纤维蛋白贴片(SSEA-1(+)祖细胞 [n = 30]),或作为假手术动物(n = 25)。在基线时以及此后每月直至4个月通过超声心动图评估左心室功能。然后对心脏进行处理以评估纤维化和血管生成情况,并通过整合4个月时与基线时左心室收缩末期容积(LVESV)的绝对变化以及基于定量聚合酶链反应(qPCR)的利钠肽A和B、肌球蛋白重链7和骨膜蛋白的表达构建一个五成分心力衰竭评分。所有数据均以盲法记录和分析。

结果

细胞治疗组的功能结局始终优于假手术组(EF的p = 0.002;LVESV的p = 0.01)。细胞 - 纤维蛋白组边缘区的血管生成也显著更多(p = 0.006),其心力衰竭评分最低(与假手术组相比p = 0.04)。移植后不久仅检测到植入的祖细胞;4个月后未发现移植细胞。未发现畸胎瘤。

结论

负载ESC来源的心脏祖细胞的纤维蛋白支架可使收缩力持续改善并减轻重塑,而无需持续的供体细胞植入。一种可能作用于固有修复反应的旁分泌效应可能是这种持久效应的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验